A weekly symptom-assessment intervention led by trained lay health workers may help reduce acute care use and improve ...

The addition of postsurgical atezolizumab immunotherapy to standard-of-care chemotherapy in patients with stage III deficient ...

Amgen Inc. (NASDAQ:AMGN)’s thrombocytopenia drug Nplate (romiplostim) showed significant benefits in a Phase III trial for ...

Hecht, MD, discusses the phase 3 OrigAMI-3 trial for patients with recurrent, unresectable, or metastatic RAS/BRAF wild-type colorectal cancer.

Patient-reported outcomes collected through an electronic health record-integrated symptom management program did not ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

According to the 2022 national cancer registration statistics, the number of gastric cancer patients was 356,507, accounting ...

An exercise program can reduce the risk that colorectal cancer will return after surgery and chemotherapy, according to a new ...

Active Together is a pioneering cancer exercise service, developed by Sheffield Hallam University’s Advanced Wellbeing ...